164 related articles for article (PubMed ID: 22197034)
1. Incidence and mortality of Parkinson's disease in older Canadians.
Allyson Jones C; Wayne Martin WR; Wieler M; King-Jesso P; Voaklander DC
Parkinsonism Relat Disord; 2012 May; 18(4):327-31. PubMed ID: 22197034
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Parkinson's disease in Bulgaria.
Hristova D; Zachariev Z; Mateva N; Grozdev I
Neuroepidemiology; 2010; 34(2):76-82. PubMed ID: 20016216
[TBL] [Abstract][Full Text] [Related]
3. Population prevalence and incidence of Parkinson's disease in an Australian community.
Mehta P; Kifley A; Wang JJ; Rochtchina E; Mitchell P; Sue CM
Intern Med J; 2007 Dec; 37(12):812-4. PubMed ID: 17561942
[TBL] [Abstract][Full Text] [Related]
4. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease.
Kaltenboeck A; Johnson SJ; Davis MR; Birnbaum HG; Carroll CA; Tarrants ML; Siderowf AD
Parkinsonism Relat Disord; 2012 May; 18(4):321-6. PubMed ID: 22177623
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.
Goldsmith JR; Herishanu YO; Podgaietski M; Kordysh E
Environ Res; 1997; 73(1-2):156-61. PubMed ID: 9311541
[TBL] [Abstract][Full Text] [Related]
6. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.
de Rijk MC; Launer LJ; Berger K; Breteler MM; Dartigues JF; Baldereschi M; Fratiglioni L; Lobo A; Martinez-Lage J; Trenkwalder C; Hofman A
Neurology; 2000; 54(11 Suppl 5):S21-3. PubMed ID: 10854357
[TBL] [Abstract][Full Text] [Related]
9. Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Pharmacoepidemiol Drug Saf; 2001; 10(6):549-54. PubMed ID: 11828838
[TBL] [Abstract][Full Text] [Related]
10. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up.
Fall PA; Saleh A; Fredrickson M; Olsson JE; Granérus AK
Mov Disord; 2003 Nov; 18(11):1312-6. PubMed ID: 14639673
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
12. Prognosis with Parkinson's disease in europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.
Berger K; Breteler MM; Helmer C; Inzitari D; Fratiglioni L; Trenkwalder C; Hofman A; Launer LJ
Neurology; 2000; 54(11 Suppl 5):S24-7. PubMed ID: 10854358
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease mortality among male anesthesiologists and internists.
Peretz C; Alexander BH; Nagahama SI; Domino KB; Checkoway H
Mov Disord; 2005 Dec; 20(12):1614-7. PubMed ID: 16078210
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
Linder J; Stenlund H; Forsgren L
Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study.
Etminan M; Carleton BC; Samii A
J Clin Neurosci; 2008 May; 15(5):576-7. PubMed ID: 18343119
[TBL] [Abstract][Full Text] [Related]
16. Mortality from Parkinson's disease: a population-based prospective study (NEDICES).
Posada IJ; Benito-León J; Louis ED; Trincado R; Villarejo A; Medrano MJ; Bermejo-Pareja F
Mov Disord; 2011 Dec; 26(14):2522-9. PubMed ID: 21915906
[TBL] [Abstract][Full Text] [Related]
17. Trends in Parkinson's disease related mortality in England and Wales, 1993-2006.
Mylne AQ; Griffiths C; Rooney C; Doyle P
Eur J Neurol; 2009 Sep; 16(9):1010-6. PubMed ID: 19538202
[TBL] [Abstract][Full Text] [Related]
18. Geographic distribution of deaths due to Parkinson's disease in Canada: 1979-1986.
Svenson LW
Mov Disord; 1990; 5(4):322-4. PubMed ID: 2259356
[TBL] [Abstract][Full Text] [Related]
19. The effect of revised populations on mortality statistics for the United States, 2000.
Anderson RN; Arias E
Natl Vital Stat Rep; 2003 Jun; 51(9):1-24. PubMed ID: 12795490
[TBL] [Abstract][Full Text] [Related]
20. Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.
Yamawaki M; Kusumi M; Kowa H; Nakashima K
Neuroepidemiology; 2009; 32(4):263-9. PubMed ID: 19209006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
